Tuesday, April 9, 2013

Pulmonary Embolism




Pulmonary Embolism

Swan-Ganz catheter in pulmonary hypertension:  sign of decreased cardiac outout is reduced mixed venous O2.  (Fick principle)

metamphetamine cause of Pulmonary HTN

Pulmonary Embolism


Classic: Stasis, Hypercoagulability and 
endothelial damage (Virchow’s triad)
• Now thought of as acquired or congenital
• Congenital: Thrombophilia (Factor V Leiden, 
Thrombin gene mutations, protein C&S 

deficiency, AT III deficiency)
• Acquired: Immobility of Lower Extremities, 
Surgery (esp. orthopedic of LE), trauma, stroke, 
heart failure, medical illness, critical illness, 
pregnancy, exogenous estrogens, malignancy, 
inflammatory disorders, nephrotic syndrome, 
APLA, smoking, age.



Clinical Signs



• 
Pulmonary: Increased 
respiratory rate, 
Hypoxemia, Crackles, 
Pleural friction rub

• Cardiac: Tachycardia,
hypotension, Right sided 
S4, Elevated jugular 
venous pressure, Increased 
P2.

• Extremities: Leg swelling,
redness. 







• Clinical Signs and Symptoms of DVT? Yes +3
• PE Is #1 Diagnosis, or Equally Likely Yes +3
• Heart Rate > 100? Yes +1.5
• Immobilization at least 3 days, or Surgery in the Previous 4 weeks Yes +1.5
• Previous, objectively diagnosed PE or DVT? Yes +1.5
• Hemoptysis? Yes +1
• Malignancy w/ Treatment within 6 mo, or palliative? Yes +1
• Score interp: <2 points 3.4% chance of PE
• 2-6 points 27.8% chance of PE
• >6 point 78% chance of PE

Diagnostic Tests for PE


• D-dimer and dead-space measurement
• Assessment of lower extremities for DVT
• Ventilation / Perfusion Scanning  (gives probability answer)
• CT angiography of pulmonary arteries = most commonly done test (yes or no answer)
• MRI thorax for PE
• Pulmonary Angiography - no advantage over CT angio

Treatment of PE



• 
Anticoagulation with heparin 
or Low Molecular Weight 
Heparin or Fondaparinux 

then coumadin
• Removal of aggravating
cause when possible

• Thrombolysis for
hemodynamically unstable 
patients

• IVC filters in cases of LE
DVT in patients who cannot 
be anti-coagulated




No comments: